Purchase Order 75N90021P00151

This purchase order awarded by the National Institutes of Health's National Center for Advancing Translational Sciences to Research and Diagnostic Systems, Inc. is valued at $445,214.70 to deliver 89 items including 27 types of recombinant human proteins and 12 small molecule compounds by June 30, 2021. As the sole source provider, Research and Diagnostic Systems will ship the products from its Minneapolis location within 14 days of each order to support the Center's consistent research...

<p>The National Institutes of Health Clinical Center issued a purchase order to Cellgenix USA for $23,182.50 on February 5, 2020, for human interleukin 4 for use in NIH protocols. The order carries a firm fixed price and concludes on February 14, 2020. Place of performance is Portsmouth, New Hampshire.</p>

The NIH Clinical Center awarded a purchase order to Research and Diagnostic Systems, Inc. for $10,908.09 on May 8, 2018, with completion by June 15, 2018. Place of performance is Bethesda, Maryland. The order is firm-fixed-price for biological research materials and laboratory supplies supporting biomedical research at the Clinical Center, consistent with the vendor's established product line of recombinant proteins, antibodies, ELISA kits, cytokine assays, and specialized research reagents.

<p>The National Institute of Child Health and Human Development awarded a purchase order to Research And Diagnostic Systems, Inc. for a variety of antibodies valued at $34,920.35, effective September 20, 2018, with completion targeted for September 20, 2019. Place of performance is Minneapolis, Minnesota. The order was issued under open competition with no set-aside applied, following a solicitation posted August 13, 2018 and due August 22, 2018.</p>

The NIH Clinical Center awarded a purchase order to Research And Diagnostic Systems, Inc. for $11,150.10 on April 23, 2020. The order covers human ACE-2 antibody, human EMMPRIN/DC147 antibody, human adhesion molecule magnetic Luminex performance assay, and human magnetic Luminex assay materials. Place of performance is Minneapolis, Minnesota. The award was designated under the National Interest Action Code for Coronavirus COVID-19 and was issued at firm fixed price with no small business...

The National Cancer Institute awarded a purchase order to Research And Diagnostic Systems, Inc. for $10,893.70 on December 15, 2020, for biological and reagent material, with completion on January 8, 2021. Place of performance is Minneapolis, Minnesota. The order carries no set-aside designation and is priced firm fixed price. Research And Diagnostic Systems, a for-profit manufacturer of biological research materials and subsidiary of Bio-Techne Corporation, supplies recombinant human...

<p>The NIH Clinical Center awarded a purchase order to Integrated DNA Technologies, Inc. for $5,040 on January 9, 2018, with completion targeted for January 19, 2018. The order is firm fixed price with no set-aside applied. Performance occurs in Bethesda, Maryland. The purchase order procures specialized nucleic acid products and molecular biology supplies, including custom DNA and RNA oligonucleotides, primers, probes, and related reagents supporting biomedical research initiatives.</p>

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $15,363 delivery order to Illumina, Inc. to provide reagents needed by the Department of Laboratory Medicine. The firm fixed price order is for the delivery of laboratory reagents to support the work of the Department of Laboratory Medicine at the NIH Clinical Center in San Diego, California. The period of performance is from July 27, 2023 through August 26, 2023. No major subcontractors or set...

<p>The NIH Clinical Center issued a $20,266 delivery order to Illumina, Inc. on March 29, 2021, for transfusion reagents. Place of performance is San Diego, CA 92122. The order was firm fixed price with an ultimate completion date of April 9, 2021.</p>

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $24,250.50 firm fixed price purchase order to Research And Diagnostic Systems, Inc., doing business as R&amp;D Systems, a division of Bio-Techne Corporation. The contract is for research and development reagents to be delivered from October 17, 2023 through November 6, 2023. As the prime contractor, R&amp;D Systems will provide laboratory supplies and materials to support the NIH Clinical Center's...